www.obroncology.com Open in urlscan Pro
13.226.145.65  Public Scan

Form analysis
3 forms found in the DOM

<form class="nav-search-form NavSearchForm_nav-search-form__2CvyZ" autocomplete="off">
  <div class="form-wrap">
    <div class="input-wrap static-label search-wrap"><button type="button" tabindex="-1" class="clear-search" aria-label="clear search"><svg class="remedy-icon" data-testid="times-icon"
          style="display:inline-block;stroke:currentColor;fill:currentColor;width:1em;height:1em" viewBox="0 0 1024 1024">
          <path
            d="M920.348 1006.698l-408.231-412.314-408.231 412.314c-10.345 10.668-24.811 17.289-40.823 17.289s-30.478-6.621-40.809-17.274l-0.014-0.015c-10.453-10.583-16.909-25.134-16.909-41.192s6.456-30.61 16.915-41.198l-0.006 0.006 407.998-412.392-407.998-412.119c-10.457-10.624-16.914-25.213-16.914-41.309s6.457-30.685 16.921-41.317l-0.008 0.008c10.377-10.599 24.833-17.171 40.823-17.171s30.446 6.571 40.813 17.161l0.010 0.010 408.231 412.314 407.998-412.314c10.417-10.513 24.86-17.022 40.823-17.022s30.406 6.509 40.819 17.018l0.004 0.004c10.457 10.624 16.914 25.213 16.914 41.309s-6.457 30.685-16.921 41.317l0.008-0.008-408.231 412.119 408.231 412.392c10.453 10.583 16.909 25.134 16.909 41.192s-6.456 30.61-16.915 41.198l0.006-0.006c-10.345 10.668-24.811 17.289-40.823 17.289s-30.478-6.621-40.809-17.274l-0.014-0.015z">
          </path>
        </svg></button><input type="text" aria-label="search" id="search" name="q" required="" value=""><label for="search">What can we help you find?</label></div><span></span><button type="submit" class="btn btn search-btn" disabled=""
      aria-label="search"><span class="util-show-after-tablet-portrait">search</span><span class="util-hide-after-tablet-portrait"><svg class="remedy-icon" style="display:inline-block;stroke:currentColor;fill:currentColor;width:1em;height:1em"
          viewBox="0 0 1024 1024">
          <path
            d="M128.326 448.326c-0.010-0.929-0.015-2.026-0.015-3.124 0-175.014 141.877-316.891 316.891-316.891 1.099 0 2.196 0.006 3.292 0.017l-0.168-0.001c0.929-0.010 2.026-0.015 3.124-0.015 175.014 0 316.891 141.877 316.891 316.891 0 1.099-0.006 2.196-0.017 3.292l0.001-0.168c0.010 0.929 0.015 2.026 0.015 3.124 0 175.014-141.877 316.891-316.891 316.891-1.099 0-2.196-0.006-3.292-0.017l0.168 0.001c-0.929 0.010-2.026 0.015-3.124 0.015-175.014 0-316.891-141.877-316.891-316.891 0-1.099 0.006-2.196 0.017-3.292l-0.001 0.168zM915.526 1005.126c11.465 11.465 27.305 18.557 44.8 18.557 34.991 0 63.357-28.366 63.357-63.357 0-17.495-7.091-33.335-18.557-44.8l-198.4-198.4c55.918-72.812 89.612-165.235 89.612-265.529 0-1.15-0.004-2.299-0.013-3.447l0.001 0.176c0.005-0.818 0.009-1.784 0.009-2.751 0-245.909-199.348-445.257-445.257-445.257-0.968 0-1.934 0.003-2.9 0.009l0.149-0.001c-0.818-0.005-1.784-0.009-2.751-0.009-245.909 0-445.257 199.348-445.257 445.257 0 0.968 0.003 1.934 0.009 2.9l-0.001-0.149c-0.005 0.818-0.009 1.784-0.009 2.751 0 245.909 199.348 445.257 445.257 445.257 0.968 0 1.934-0.003 2.9-0.009l-0.149 0.001c0.972 0.008 2.121 0.012 3.271 0.012 100.293 0 192.717-33.694 266.57-90.379l-1.041 0.767z">
          </path>
        </svg></span></button>
  </div>
</form>

POST

<form class="newsletter-form NewsletterForm_newsletter-form__1hbGR" novalidate="" method="post" autocomplete="on"><input type="hidden" name="group[3717][512]" id="mce-group[3717]-3717-14" value="512">
  <div class="input-wrap static-label"><input type="email" aria-label="email address" id="email" name="email" placeholder="Enter your email" required="" pattern="^[a-zA-Z0-9._%+-]+@[a-zA-Z0-9.-]+\.[a-zA-Z]{2,}$" value="" autocorrect="off"><label
      for="email">email address<span aria-hidden="true">required</span></label></div><input type="submit" class="btn btn-secondary" value="sign up">
</form>

POST

<form class="newsletter-form NewsletterForm_newsletter-form__1hbGR" novalidate="" method="post" autocomplete="on"><input type="hidden" name="group[3717][512]" id="mce-group[3717]-3717-14" value="512">
  <div class="input-wrap static-label"><input type="email" aria-label="email address" id="email" name="email" placeholder="Enter your email" required="" pattern="^[a-zA-Z0-9._%+-]+@[a-zA-Z0-9.-]+\.[a-zA-Z]{2,}$" value="" autocorrect="off"><label
      for="email">email address<span aria-hidden="true">required</span></label></div><input type="submit" class="btn btn-secondary" value="sign up">
</form>

Text Content

 * Newsletters
 * 
 * 

What can we help you find?
search
Cancer Types
 * Bladder Cancer
 * Breast Cancer
 * Chronic Lymphocytic Leukemia (CLL)
 * Colorectal Cancer
 * Hepatocellular Carcinoma (HCC)
 * Lung Cancer
 * Multiple Myeloma
 * Non-Hodgkin's Lymphoma (NHL)
 * Ovarian Cancer
 * Prostate Cancer
 * Renal Cell Carcinoma (RCC)
 * All Cancer Types

Conferences
 * ASCO Annual Meeting Conference Coverage
 * ASCO GI Conference Coverage
 * ASCO GU Conference Coverage
 * ASH Conference Coverage
 * COA Conference Coverage
 * ESMO Conference Coverage
 * SABCS Conference Coverage
 * SNO Conference Coverage
 * All Conference Coverage

Expert Insights
 * Case Studies
 * Clinical Roundtables
 * Journal Scans
 * Leading Thoughts
 * Peer-Spectives Podcast
 * Video Center

Business & Policy
 * Oncology Business
 * Policy and Value
 * OBR Radar
 * COA Conference Coverage
 * ACCC / CCBS Conference Coverage

SIGN UP FOR OUR NEWSLETTERS!

Join our OBR community to get the best oncology news curated from across the
web.

email addressrequired
 * Privacy Policy
 * Terms of Use
 * Advertising Policy
 * Advertise With Us
 * Remedy Health Media Sites
 * Do Not Sell My Info

 * About Us
 * Editorial Board
 * Contact Us
 * Training

Follow us!


© 2021 Remedy Health Media, LLC ALL RIGHTS RESERVED

Immuno-Oncology



FIRST OPINION: PROPOSALS TO CAP MEDICARE PART B PAYMENTS WILL LIMIT OUTPATIENT
ACCESS TO CAR-T

Sep 22, 2021


(STAT) Sep 22, 2021 - The revolutionary life-extending approach to treating
cancer known as CAR-T is under threat from a quotidian source: policy proposals
to limit Medicare reimbursement in the outpatient setting to the average sales
price of the treatment plus a small addition for overhead.



Read More 
This link leaves our website.

RELATED

ESMO Conference CoverageSEP 18

ADJUVANT IMMUNOTHERAPY IN HIGH-RISK MELANOMA

Marcus A. Banks

ESMO Conference CoverageSEP 18

I-O EXTENDS CERVICAL CANCER SURVIVAL

Aaron Tallent

World Lung Conference CoverageSEP 14

ICIS BENEFIT THE ELDERLY WITH NSCLC

Christina Bennett

World Lung Conference CoverageSEP 10

I-O COMBO PLUS CHEMO IMPROVES SURVIVAL IN NSCLC

Chase Doyle



SIGN UP FOR OUR NEWSLETTERS!

Join our OBR community to get the best oncology news curated from across the
web.

email addressrequired
 * Privacy Policy
 * Terms of Use
 * Advertising Policy
 * Advertise With Us
 * Remedy Health Media Sites
 * Do Not Sell My Info

 * About Us
 * Editorial Board
 * Contact Us
 * Training

Follow us!


© 2021 Remedy Health Media, LLC ALL RIGHTS RESERVED

Start Survey